Director Innovation Core Services
(Design Control, Labeling, V&V)
Barbara Nawrot is Director of Innovation Core Services at KCI, a global medical device leader of innovative, transformational healing solutions. KCI’s is located in San Antonio where Barbara has responsibility for Design Controls, Global Product Labeling and V&V. Her teams support both new product introduction and life cycle management teams across the globe. Prior to joining KCI in 2008, Barbara was Director of Technical Operations for Cordis, a Johnson & Johnson company, located in Miami where she held a variety of positions over a 20 year period. During her career, Barbara has led numerous teams through periods of dynamic change, innovation and continuous improvement. Her interest in Structured Product Labeling (SPL) began in 2010 when KCI was one of five companies selected to work with FDA on their SPL pilot. In April 2013, Barbara appeared as a guest speaker at the FDA’s Public Meeting and continues to keep in contact with the FDA on their progress with SPL. Barbara holds an MBA from Florida Atlantic University and earned her Black Belt Certification from KCI in 2010. She can be contacted at Barbara.Nawrot@kci1.com
How many years have you been in the industry?
Too many to count – over 25.
Why do you believe that the Device & Diagnostic Labeling Conference is important?
The variety of agenda topics provides an excellent opportunity to educate and inform. When we return, the knowledge obtained is shared with our internal teams. With new information often comes new decisions and those decisions often lead to improved processes, improved quality, reduction in cycle times and most importantly a new way of thinking.
What do you hope attendees will take away from your presentation, workshop or panel discussion?
A better understanding o the topic, where it is heading and what it means to them.
What inspires your passion and/or interest for medical product labeling and/or healthcare?
It was and always has been about the patients and products that improve the standard of care.
Barbara will be one of the distinguished presenters at the Medical Device and Diagnostic Labeling Conference.